The Streptococcus genus enhances the antitumor immune response by increasing the infiltration of CD4+ CXCL13+ T cells [347], and the presence of Streptococcus in esophageal cancer can predict the response to anti‐PD‐1 therapy [348]. This evidence concerns the gene CXCL13 and esophageal cancer.